This inventor holds 3 USPTO granted patents and 1 EPO patent. Top assignee: Sanofi. Active years: 2013-2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013-2016
Title: Eva Albert: Innovator in Pharmaceutical Chemistry
Introduction
Eva Albert is a prominent inventor based in Paris, France. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of MET inhibitors. With a total of 3 patents to her name, her work is recognized for its potential impact on medical treatments.
Latest Patents
Among her latest patents, Eva has developed 6-triazolopyridazine sulfanyl benzothiazole derivatives as MET inhibitors. The disclosure relates to compounds of formula (I), wherein A, W, X, and Ra are as defined in the disclosure, and salts thereof. These compounds are integral to pharmaceutical compositions that comprise said compounds, processes for preparing them, and their use as medicaments, particularly as MET inhibitors.
Career Highlights
Eva Albert is currently employed at Sanofi, a leading global biopharmaceutical company. Her role involves extensive research and development in the field of drug discovery and formulation. Her innovative approach has led to advancements in therapeutic options for various medical conditions.
Collaborations
Eva collaborates with notable colleagues, including Eric Bacque and Conception Nemecek. Their teamwork fosters a dynamic environment for innovation and research, contributing to the success of their projects.
Conclusion
Eva Albert's contributions to pharmaceutical chemistry exemplify the vital role of inventors in advancing medical science. Her patents and collaborative efforts continue to pave the way for new treatments and innovations in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile